- Home
- CYTK vs NEU Comparison
CYTK vs NEU Comparison
Compare CYTK & NEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- NEU
- Stock Information
- Founded
- CYTK 1997
- NEU 1887
- Country
- CYTK United States
- NEU United States
- Employees
- CYTK N/A
- NEU N/A
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- NEU Major Chemicals
- Sector
- CYTK Health Care
- NEU Industrials
- Exchange
- CYTK Nasdaq
- NEU Nasdaq
- Market Cap
- CYTK 5.6B
- NEU 5.4B
- IPO Year
- CYTK 2004
- NEU N/A
- Fundamental
- Price
- CYTK $32.00
- NEU $640.30
- Analyst Decision
- CYTK Buy
- NEU
- Analyst Count
- CYTK 15
- NEU 0
- Target Price
- CYTK $73.71
- NEU N/A
- AVG Volume (30 Days)
- CYTK 2.0M
- NEU 35.0K
- Earning Date
- CYTK 05-06-2025
- NEU 07-28-2025
- Dividend Yield
- CYTK N/A
- NEU 1.72%
- EPS Growth
- CYTK N/A
- NEU 20.83
- EPS
- CYTK N/A
- NEU 50.24
- Revenue
- CYTK $19,218,000.00
- NEU $2,790,768,000.00
- Revenue This Year
- CYTK $24.01
- NEU N/A
- Revenue Next Year
- CYTK $698.33
- NEU N/A
- P/E Ratio
- CYTK N/A
- NEU $12.81
- Revenue Growth
- CYTK 412.21
- NEU 3.65
- 52 Week Low
- CYTK $29.31
- NEU $480.00
- 52 Week High
- CYTK $61.38
- NEU $653.71
- Technical
- Relative Strength Index (RSI)
- CYTK 44.20
- NEU 59.14
- Support Level
- CYTK $30.02
- NEU $630.79
- Resistance Level
- CYTK $31.27
- NEU $646.77
- Average True Range (ATR)
- CYTK 1.32
- NEU 8.54
- MACD
- CYTK 0.38
- NEU -3.27
- Stochastic Oscillator
- CYTK 72.12
- NEU 41.49
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About NEU NewMarket Corp
NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives. Petroleum additives are used in lubricating oils and fuels to enhance their performance in machinery, vehicles, and other equipment. It comprises two broad product applications. Lubricant additives are formulated chemical solutions that, when blended with base fluids, improve the efficiency, durability, performance, and functionality of mineral oils, synthetic oils, and biodegradable fluids. Fuel additives are chemical components that help oil refiners meet fuel specifications or formulated packages that improve the performance of gasoline, diesel, biofuels, and other fuels.